EW Edwards Lifesciences Corp Stock Price & News

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. CompareEW’s historical performanceagainst its industry peers and the overall market.

Short interest in Edwards Lifesciences has recently increased by 6.77%, indicating that investor sentiment is decreasing significantly. 2.12% of the float of Edwards Lifesciences has been sold short. Please log in to your account or sign up in order to add this asset to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist.

Lead Independent Director exercised options and sold US$2.4m worth of stock

Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades.

• On average, 7 Wall Street analysts forecast EW’s revenue for 2024 to be $4,107,394,706,072, with the lowest EW revenue forecast at $4,022,229,005,692, and the highest EW revenue forecast at $4,193,104,238,628.
• Visit a quote page and your recently viewed tickers will be displayed here.
• The lighter blue line represents the stock’s consensus price target.
• The chart below shows how a company’s ratings by analysts have changed over time.
• In the past three months, Edwards Lifesciences insiders have sold more of their company’s stock than they have bought.

Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. While overall activity for our top managers decreased again, our early read on the buying and selling activity during the period did uncover a few ideas worth considering.

Edwards LifeSciences: When Even A Pandemonium Makes Room

Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. Tech investors burned by earnings disappointments and recapitalization. Declining fuel prices stoked great returns at several of these companies, but that’s not a lasting advantage.

Over the previous 90 days, Edwards Lifesciences’s stock had 4 downgrades by analysts. Edwards Lifesciences’ stock is owned by a number of institutional and retail investors. (3.60%), Moneta Group Investment Advisors LLC (2.49%), Brown Advisory Inc. (2.32%), Geode Capital Management LLC (1.96%), Norges Bank (1.43%) and Amundi (1.31%).

Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price. 18 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Edwards Lifesciences in the last year.

Edwards Lifesciences Stock Slumps on Guidance Cut

The largest positive contribution comes from its “Physical diseases” impact, which is mostly driven by its “Catheters”, “Mitral valve repair devices”, and “Artificial heart valves” products. Edwards Lifesciences has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Over the last two decades, Edwards Lifesciences has demonstrated that it how to find the best stocks for day trading knows how to maintain leadership through innovation of tissue heart valves. Edwards remains the dominant force in surgical heart valves and minimally invasive valve therapy—one of the hottest areas in cardiac devices. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services.

Sign-up to receive the latest news and ratings for Edwards Lifesciences and its competitors with MarketBeat’s FREE daily newsletter. 80.35% of the stock of Edwards Lifesciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The chart below shows how a company’s ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green. According to analysts’ consensus price target of $88.95, Edwards Lifesciences has a forecasted upside of 8.6% from its current price of $81.91.

Edwards Lifesciences Corp EW:NYSE

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. Real-time analyst ratings, insider transactions, earnings data, and more.

Michael A. Mussallem has an approval rating of 90% among the company’s employees. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Only 1.29% of the stock of Edwards Lifesciences is held by insiders. Only 10 people have added Edwards Lifesciences to their MarketBeat watchlist in the last 30 days. Only 21 people have searched for EW on MarketBeat in the last 30 days. Edwards Lifesciences does not have a long track record of dividend growth.

The average Edwards Lifesciences stock price prediction forecasts a potential upside of 18.02% from the current https://day-trading.info/ of $79.48. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Intraday Data provided by FACTSET and subject to terms of use. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.

Provide specific products and services to you, such as portfolio management or data aggregation. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Represents the company’s profit divided by the outstanding shares of its common stock.

A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. Analysts like Edwards Lifesciences less than other Medical companies. The consensus rating for Edwards Lifesciences is Hold while the average consensus rating for medical companies is Buy. The newly created shares were distributed to shareholders after the closing bell on Monday, May 18th 2020. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease.

Net money flow is the value of uptick trades minus the value of downtick trades. According to analysts, Edwards Lifesciences’s stock has a predicted upside of 13.70% based on their 12-month price targets. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report.

LLP2.51Vanguard 500 Index Fund2.35BlackRock Institutional Trust Co. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index quotes are real-time. We’d like to share more about how we work and what drives our day-to-day business.